MedTrace Logo

pRESET for Occlusive Stroke Treatment

NCT03994822 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 340

Last updated 2023-04-21

No results posted yet for this study

Summary

Compare the safety and effectiveness of pRESET to Solitaire in the treatment of stroke related to large vessel occlusion

Conditions

Interventions

DEVICE

Mechanical Thrombectomy using the pRESET Thrombectomy device

Clot removal using the pRESET Thrombectomy device

DEVICE

Mechanical Thrombectomy using the Solitaire Revascularization Device

Clot removal using the Solitaire Revascularization Device

Sponsors & Collaborators

  • phenox Inc.

    lead INDUSTRY

Principal Investigators

  • Raul G Nogueira, MD · University of Pittsburgh Medical Center, Pittsburgh

  • Richardo A Hanel, MD · Baptist Medical Center Jacksonville

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-04
Primary Completion
2022-05-12
Completion
2022-05-12
FDA Device
Yes

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03994822 on ClinicalTrials.gov